Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status
- 2 August 2012
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 65 (11), 996-1002
- https://doi.org/10.1136/jclinpath-2012-200742
Abstract
Background β-2-microglobulin (B2M) is essential for antigen presentation, yet may also possess proto-oncogenic properties. Aim To determine the prognostic impact of B2M in patients with mismatch repair (MMR) proficient and deficient colorectal cancer (CRC) and to investigate whether this effect on outcome is dependent on the local immune response. Methods B2M protein expression and tumour-infiltrating immune cells (CD3, CD16, CD163, CD20, CD4, CD45RO, CD56, CD68, CD8, FoxP3, GranzymeB, iNOS, mast cell tryptase, MUM1, PD1, TIA-1) were evaluated in a well characterised tissue microarray of 408 CRCs. The predictive value for clinicopathological features and the prognostic significance of B2M expression were analysed, stratified by MMR status and the immunohistological characteristics of immune cell infiltrates. Results Interobserver agreement for B2M staining was high (intra-class correlation coefficient=0.91). Complete B2M loss was more frequent in MMR-deficient (19.4%) compared to MMR-proficient (7.1%) tumours (pConclusions Our data show for the first time that absence of B2M protein expression identifies MMR-deficient cancers with a favourable clinical course and absence of metastatic disease. Validation of B2M protein expression for sub-classification of MMR-deficient CRC is recommended for future clinical trials.Keywords
This publication has 31 references indexed in Scilit:
- Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trialBritish Journal of Cancer, 2012
- β2-Microglobulin Induces Epithelial to Mesenchymal Transition and Confers Cancer Lethality and Bone Metastasis in Human Cancer CellsCancer Research, 2011
- Clinical Relevance of Microsatellite Instability in Colorectal CancerJournal of Clinical Oncology, 2010
- Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patientsBMC Immunology, 2010
- Overexpression of β2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasionBritish Journal of Cancer, 2008
- Pathology Features in Bethesda Guidelines Predict Colorectal Cancer Microsatellite Instability: A Population-Based StudyGastroenterology, 2007
- Beta2‐microglobulin mutations in microsatellite unstable colorectal tumorsInternational Journal of Cancer, 2007
- Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysisLaboratory Investigation, 2004
- Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 downregulation in MSI‐negative tumorsTissue Antigens, 2003
- The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancerInternational Journal of Oncology, 1992